Literature DB >> 10698346

The contrasting mechanisms of serum resistance of Neisseria gonorrhoeae and group B Neisseria meningitidis.

S Ram1, F G Mackinnon, S Gulati, D P McQuillen, U Vogel, M Frosch, C Elkins, H K Guttormsen, L M Wetzler, M Oppermann, M K Pangburn, P A Rice.   

Abstract

Neisseria gonorrhoeae and Neisseria meningitidis have evolved intricate mechanisms to evade complement-mediated killing. Sialylation of gonococcal lipooligosaccharide (LOS) results in conversion of previously serum sensitive strains to unstable serum resistance, which is mediated by factor H binding. Porin (Por) is also instrumental in mediating stable serum resistance in gonococci. The 5th loop of certain gonococcal PorlAs binds factor H, which efficiently inactivates C3b to iC3b. Factor H glycan residues may be essential for factor H binding to certain Por1A strains. Por1A strains can also regulate the classical pathway by binding to C4b-binding protein (C4bp) probably via the 1st loop of the Por molecule. Certain serum resistant Por1 B strains can also regulate complement by binding C4bp through a loop other than loop 1. Purified C4b can inhibit binding of C4bp to Por 1B, but not Por1A, suggesting different binding sites on C4bp for the two Por types. Unlike serum resistant gonococci, resistant meningococci have abundant C3b on their surface, which is only partially processed to iC3b. The main mechanism of complement evasion by group B meningococci is inhibition of membrane attack complex (MAC) insertion by their polysaccharide capsule. LOS structure may act in concert with capsule to prevent MAC insertion. Meningococcal strains with Class 3 Por preferentially bind factor H, suggesting Class 3 Por acts as a receptor for factor H.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10698346     DOI: 10.1016/s0161-5890(99)00114-5

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  54 in total

1.  Killing of dsrA mutants of Haemophilus ducreyi by normal human serum occurs via the classical complement pathway and is initiated by immunoglobulin M binding.

Authors:  Malikah Abdullah; Igor Nepluev; Galyna Afonina; Sanjay Ram; Peter Rice; William Cade; Christopher Elkins
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

2.  The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance.

Authors:  Guillermo Madico; Jo Anne Welsch; Lisa A Lewis; Anne McNaughton; David H Perlman; Catherine E Costello; Jutamas Ngampasutadol; Ulrich Vogel; Dan M Granoff; Sanjay Ram
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

3.  LfhA, a novel factor H-binding protein of Leptospira interrogans.

Authors:  Ashutosh Verma; Jens Hellwage; Sergey Artiushin; Peter F Zipfel; Peter Kraiczy; John F Timoney; Brian Stevenson
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

4.  Differential expression and transcriptional analysis of the alpha-2,3-sialyltransferase gene in pathogenic Neisseria spp.

Authors:  Mathanraj Packiam; Dawn M Shell; Shi V Liu; Yao-Bin Liu; David J McGee; Ranjana Srivastava; Samar Seal; Richard F Rest
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

5.  Acute septic arthritis: remember gonorrhea.

Authors:  M Dalla Vestra; C Rettore; P Sartore; E Velo; L Sasset; G Chiesa; L Marcon; L Scarano; N Simioni; L Bacelle; G M Patrassi
Journal:  Rheumatol Int       Date:  2008-05-24       Impact factor: 2.631

6.  Acquisition of factor H by a novel surface protein on group B Streptococcus promotes complement degradation.

Authors:  Ravi Maruvada; Nemani V Prasadarao; C E Rubens
Journal:  FASEB J       Date:  2009-07-16       Impact factor: 5.191

Review 7.  Antimicrobial peptide resistance in Neisseria meningitidis.

Authors:  Yih-Ling Tzeng; David S Stephens
Journal:  Biochim Biophys Acta       Date:  2015-05-19

8.  Defining targets for complement components C4b and C3b on the pathogenic neisseriae.

Authors:  Lisa A Lewis; Sanjay Ram; Alpana Prasad; Sunita Gulati; Silke Getzlaff; Anna M Blom; Ulrich Vogel; Peter A Rice
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

Review 9.  Outer membrane proteins of pathogenic spirochetes.

Authors:  Paul A Cullen; David A Haake; Ben Adler
Journal:  FEMS Microbiol Rev       Date:  2004-06       Impact factor: 16.408

10.  Borrelia recurrentis employs a novel multifunctional surface protein with anti-complement, anti-opsonic and invasive potential to escape innate immunity.

Authors:  Sonja Grosskinsky; Melanie Schott; Christiane Brenner; Sally J Cutler; Peter Kraiczy; Peter F Zipfel; Markus M Simon; Reinhard Wallich
Journal:  PLoS One       Date:  2009-03-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.